{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T15:41:24Z","timestamp":1684856484959},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T00:00:00Z","timestamp":1231804800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00277-008-0692-4","type":"journal-article","created":{"date-parts":[[2009,1,12]],"date-time":"2009-01-12T14:41:11Z","timestamp":1231771271000},"page":"921-922","source":"Crossref","is-referenced-by-count":5,"title":["Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphoma"],"prefix":"10.1007","volume":"88","author":[{"given":"Adrian","family":"Tempescul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Christophe","family":"Ianotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Morel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Marion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"De Braekeleer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Berthou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,13]]},"reference":[{"issue":"2","key":"692_CR1","first-page":"115","volume":"36","author":"E Campo","year":"1999","unstructured":"Campo E, Raffeld M, Jaffe ES (1999) Mantle-cell lymphoma. Semin Hematol 36(2):115\u2013127 (review)","journal-title":"Semin Hematol"},{"issue":"5","key":"692_CR2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11912-007-0053-9","volume":"9","author":"A Goy","year":"2007","unstructured":"Goy A (2007) Mantle cell lymphoma: evolving novel options. Curr Oncol Rep 9(5):391\u2013398 (review), doi: 10.1007\/s11912-007-0053-9","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"692_CR3","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V83.3.758.758","volume":"83","author":"A Manabe","year":"1994","unstructured":"Manabe A, Murti KG, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Campana D (1994) Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood 83(3):758\u2013766","journal-title":"Blood"},{"issue":"1","key":"692_CR4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1084\/jem.183.1.227","volume":"183","author":"P Merville","year":"1996","unstructured":"Merville P, D\u00e9chanet J, Desmouli\u00e8re A, Durand I, de Bouteiller O, Garrone P, Banchereau J, Liu YJ (1996) \u2212Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J Exp Med 183(1):227\u2013236. doi: 10.1084\/jem.183.1.227","journal-title":"J Exp Med"},{"issue":"1","key":"692_CR5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.163.1.380","volume":"163","author":"LG Corral","year":"1999","unstructured":"Corral LG, Haslett PA, Muller GW, Chen R, Wong LM, Ocampo CJ, Patterson RT, Stirling DI, Kaplan G (1999) Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol 163(1):380\u2013386","journal-title":"J Immunol"},{"issue":"7","key":"692_CR6","first-page":"1105","volume":"47","author":"B Settles","year":"2001","unstructured":"Settles B, Stevenson A, Wilson K, Mack C, Ezell T, Davis MF, Taylor LD (2001) Down-regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vitro treatment with the anti-TNF-alpha agent thalidomide. Cell Mol Biol 47(7):1105\u20131114","journal-title":"Cell Mol Biol"},{"issue":"8","key":"692_CR7","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood-2004-03-1091","volume":"104","author":"H Kaufmann","year":"2004","unstructured":"Kaufmann H, Raderer M, W\u00f6hrer S, P\u00fcsp\u00f6k A, Bankier A, Zielinski C, Chott A, Drach J (2004) Antitumor activity of rituximab plus thalidomide in patients with relapsed\/refractory mantle cell lymphoma. Blood 104(8):2269\u20132271. doi: 10.1182\/blood-2004-03-1091","journal-title":"Blood"},{"issue":"9","key":"692_CR8","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/sj.leu.2403058","volume":"17","author":"G Damaj","year":"2003","unstructured":"Damaj G, Lefr\u00e8re F, Delarue R, Varet B, Furman R, Hermine O (2003) Thalidomide therapy induces response in relapsed mantle cell lymphoma. Leukemia 17(9):1914\u20131915. doi: 10.1038\/sj.leu.2403058","journal-title":"Leukemia"},{"issue":"1","key":"692_CR9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2141.2002.03810.x","volume":"119","author":"EA Wilson","year":"2002","unstructured":"Wilson EA, Jobanputra S, Jackson R, Parker AN, McQuaker IG (2002) Response to thalidomide in chemotherapy-resistant mantle cell lymphoma: a case report. Br J Haematol 119(1):128\u2013130. doi: 10.1046\/j.1365-2141.2002.03810.x","journal-title":"Br J Haematol"},{"issue":"3","key":"692_CR10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2141.2007.06937.x","volume":"140","author":"SM Smith","year":"2008","unstructured":"Smith SM, Grinblatt D, Johnson JL, Niedzwiecki D, Rizzieri D, Bartlett NL, Cheson BD, Cancer and Leukemia Group B (2008) Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B. Br J Haematol 140(3):313\u2013319. doi: 10.1111\/j.1365-2141.2007.06937.x","journal-title":"Br J Haematol"},{"key":"692_CR11","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1200\/jco.2007.25.18_suppl.8030","volume":"25","author":"M Wang","year":"2007","unstructured":"Wang M, Fayad L, Hegemeister F et al (2007) A phase I\/II study of lenalidomide in combination with rituximab in relapsed\/refractory mantle cell lymphoma with early evidence of efficacy. J Clin Oncol 25:8030","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0692-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-008-0692-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0692-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T15:26:43Z","timestamp":1684855603000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-008-0692-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,13]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["692"],"URL":"https:\/\/doi.org\/10.1007\/s00277-008-0692-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,13]]}}}